74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Balchem Corp
Closed
SectorBasic materials
154.2 -2.45
Overview
Share price change
24h
Min
143.92
Max
157.5
Income | -254K 34M |
|---|---|
Sales | 64K 240M |
P/E Sector Avg | 40.031 43.137 |
EPS | 1.13 |
Dividend yield | 0.55 |
Profit margin | 13.993 |
Employees | 1,361 |
EBITDA | -11M 47M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +28.23% upside |
Dividend yield Sector Avg | 0.55% 3.06% |
|---|
Market Cap | 54M 5.3B |
|---|---|
Previous open | 156.65 |
Previous close | 154.2 |
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Balchem Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Balchem Corp Forecast
Price Target
By TipRanks
28.23% upside
12 Months Forecast
Average 203 USD 28.23%
High 216 USD
Low 190 USD
Based on 2 Wall Street analysts offering 12 month price targets forBalchem Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Balchem Corp
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
